NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 83 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $202,000 | -37.7% | 196,421 | +14.1% | 0.00% | – |
| Q1 2022 | $324,000 | +6.2% | 172,114 | +171.8% | 0.00% | – |
| Q4 2021 | $305,000 | +61.4% | 63,315 | +142.0% | 0.00% | – |
| Q3 2021 | $189,000 | -21.9% | 26,159 | +52.6% | 0.00% | – |
| Q4 2020 | $242,000 | -55.8% | 17,142 | -48.1% | 0.00% | -100.0% |
| Q2 2020 | $548,000 | +47.3% | 33,005 | +1.1% | 0.00% | 0.0% |
| Q1 2020 | $372,000 | -67.0% | 32,654 | -64.3% | 0.00% | 0.0% |
| Q4 2019 | $1,127,000 | +237.4% | 91,511 | -21.9% | 0.00% | – |
| Q3 2019 | $334,000 | – | 117,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |